Please provide your email address to receive an email when new articles are posted on . Patients with pediatric discoid lupus erythematosus combined with systemic lupus erythematosus were most likely ...

Most people with lupus have it affect the skin. The types of rashes can be divided into two large groups. First, when lupus affects the skin with problems only seen in lupus, it’s called cutaneous ...

Please provide your email address to receive an email when new articles are posted on . Diagnosis of discoid lupus erythematosus in patients aged younger than 25 years may predict the onset of severe ...

The display and use of drug information on this site is subject to express terms of use. By continuing to view the drug information, you agree to abide by such terms ...

This transcript has been edited for clarity. For more episodes, download the Medscape app or subscribe to the podcast on Apple Podcasts, Spotify, or your preferred podcast provider. Maureen A. McMahon ...

SAN ANTONIO — Distinguishing between the various forms of cutaneous lupus can be challenging, even for experienced clinicians. If a patient presents with a malar rash — also known as a butterfly rash ...

Imagine your body attacking itself. That’s what happens with lupus, a chronic autoimmune disease affecting millions worldwide. Lupus Alert Day is a chance to shine a spotlight on this condition. It’s ...

A biopsy of one of the papules revealed vacuolar change at the dermal-epidermal junction, follicular plugging, and hyperkeratosis. The girl was diagnosed with discoid lupus erythematosus (DLE) ...

Background A 64-year-old man was admitted to hospital with increasing seizure frequency, lethargy and confusion. He had a history of discoid lupus erythematosus, complex partial seizures, cerebral ...

TUESDAY, Sept. 23, 2025 (HealthDay News) — Systemic lupus erythematosus (SLE), often simply called lupus, is a chronic autoimmune disease in which the body's immune system malfunctions and mistakenly ...

DUBLIN--(BUSINESS WIRE)-- Horizon Therapeutics plc (Nasdaq: HZNP) today announced the first patient has enrolled in a Phase 2, randomized, placebo-controlled trial to evaluate its development-stage ...